Efficacy and Safety of a Neurokinin-1 Receptor Antagonist in Postmenopausal Women With Overactive Bladder With Urge Urinary Incontinence

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2535-2540

  Green, Stuart A ^a   Alon, Achilles ^a   Ianus, Juliana ^a   McNaughton, Kristin S ^a   Tozzi, Carol A ^a   Reiss, Theodore F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

antagonists and inhibitors; controlled clinical trial; neurokinin 1; receptors; urinary incontinence

Indexed keywords

APREPITANT; NEUROKININ 1 RECEPTOR ANTAGONIST; PLACEBO;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEART PALPITATION; HUMAN; LEUKOCYTE DISORDER; MAJOR CLINICAL STUDY; MICTURITION; OVERACTIVE BLADDER; PILOT STUDY; PNEUMONIA; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; URGE INCONTINENCE; URINARY TRACT INFECTION; URINARY URGENCY; URINE INCONTINENCE; XEROSTOMIA;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; MORPHOLINES; PILOT PROJECTS; POSTMENOPAUSE; RECEPTORS, NEUROKININ-1; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE;

EID: 33750520115     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.018     Document Type: Article

References (22)

1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167
2. Stewart W.F., Van Rooyen J.B., Cundiff G.W., Abrams P., Herzog A.R., Corey R., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 (2003) 327
3. Wyman J.F., Harkins S.W., Choi S.C., Taylor J.R., and Fantl J.A. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 70 (1987) 378
4. Wein A.J. Pharmacologic treatment of incontinence. J Am Geriatr Soc 38 (1990) 317
5. Lecci A., and Maggi C.A. Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 101 (2001) 1
6. Bergstrom M., Hargreaves R.J., Burns H.D., Goldberg M.R., Sciberras D., Reines S.A., et al. Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry 55 (2004) 1007
7. Brown J.S., McNaughton K.S., Wyman J.F., Burgio K.L., Harkaway R., Bergner D., et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 61 (2003) 802
8. Lubeck D.P., Prebil L.A., Peeples P., and Brown J.S. A health related quality of life measure for use in patients with urge urinary incontinence: a validation study. Qual Life Res 8 (1999) 337
9. Wagner T.H., Patrick D.L., Bavendam T.G., Martin M.L., and Buesching D.P. Quality of life of persons with urinary incontinence: development of a new measure. Urology 47 (1996) 67
10. Gail M., and Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 41 (1985) 361
11. Miettinen O., and Nurminen M. Comparative analysis of two rates. Stat Med 4 (1985) 213
12. Landis J.R., Kaplan S., Swift S., and Versi E. Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171 (2004) 752
13. Scheife R., and Takeda M. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther 27 (2005) 144
14. De Groat W.C., Downie J.W., Long Lin A.T., Morrison J.F.B., Nishizawa O., Steers W.D., et al. Neurophysiology and neuropharmacology. In: Abrams P., Koury S., and Wein A. (Eds). Incontinence: Proceedings of the 1st International Consultation on Incontinence, Monaco, June 28-July 1, 1998 (1999), Health Publications Ltd, Plymouth, United Kingdom 107-154
15. Coolsaet B.L., Van Duyl W.A., Van Os-Bossagh P., and De Bakker H.V. New concepts in relation to urge and detrusor activity. Neurourol Urodyn 12 (1993) 463
16. Chancellor M.B., and de Groat W.C. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162 (1999) 3
17. Cheng C.L., Ma C.P., and de Groat W.C. Effect of capsaicin on micturition and associated reflexes in chronic spinal rats. Brain Res 678 (1995) 40
18. Lecci A., Giuliani S., Santicioli P., and Maggi C.A. Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats. Eur J Pharmacol 259 (1994) 129
19. Kamo I., Imai S., Okanishi S., and Doi T. Possible site of action of TAK-637, a tachykinin NK(1) receptor antagonist, on the micturition reflex in guinea pigs. Eur J Pharmacol 401 (2000) 235
20. Diokno A., Sand P., Labasky R., Sieber P., Antoci J., Leach G., et al. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol 34 (2002) 43
21. de Wit R., Herrstedt J., Rapoport B., Carides A.D., Carides G., Elmer M., et al. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. J Clin Oncol 21 (2003) 4105
22. Martin J.L., Williams K.S., Abrams K.R., Turner D.A., Sutton A.J., Chapple C., et al. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess 10 (2006) 1